Clindamycin is Preferred Over Erythromycin for Cellulitis Treatment
For uncomplicated cellulitis, clindamycin is the superior choice compared to erythromycin due to rising resistance rates to erythromycin and clindamycin's proven efficacy, though neither is a first-line agent.
Current Resistance Patterns Make This Decision Critical
The 2014 IDSA guidelines explicitly warn that resistance of S. aureus to erythromycin has "dramatically increased" and resistance of streptococci to both erythromycin and clindamycin has been reported 1. This fundamentally changes the historical landscape where both agents were once reliably effective against the primary cellulitis pathogens (S. aureus and β-hemolytic streptococci).
When to Use Each Agent
First-Line Therapy (Not Erythromycin or Clindamycin)
For typical uncomplicated cellulitis, use penicillin, amoxicillin, cephalexin, or dicloxacillin first 1. These β-lactams remain the standard of care for non-purulent cellulitis, which is predominantly streptococcal.
Clindamycin as Second-Line
Clindamycin is appropriate when:
- Penicillin allergy exists 1
- Dual coverage needed: When you suspect both streptococci AND MRSA (penetrating trauma, IV drug use, purulent drainage, concurrent MRSA infection elsewhere) - clindamycin covers both 1
- Patient cannot tolerate β-lactams
Erythromycin: Rarely Appropriate
Erythromycin should generally be avoided due to:
- High resistance rates in both S. aureus and streptococci 1
- No comparative advantage over clindamycin
- Meta-analysis shows macrolides (including erythromycin) have similar efficacy to β-lactams overall, but this doesn't account for local resistance patterns 2
Dosing Specifics
Clindamycin Dosing
- Adults: 300-450 mg orally every 6-8 hours
- Weight-based dosing matters: Use ≥10 mg/kg/day for optimal outcomes. Inadequate dosing (<10 mg/kg/day) doubles the risk of clinical failure (30% vs 17%, OR 2.01) 3
- Duration: 5 days if clinical improvement achieved; otherwise up to 10-14 days 1
Erythromycin Dosing (if used despite limitations)
- Adults: 250-500 mg orally four times daily 4
- Children: 30-50 mg/kg/day in divided doses 4
- Take on empty stomach for optimal absorption (30 minutes to 2 hours before meals) 4
Safety Considerations
Clindamycin Side Effects
- Diarrhea is common: 22% incidence in clinical trials, significantly higher than β-lactams alone (9%, OR 2.7) 5
- Monitor for C. difficile colitis, especially with prolonged use
- Generally well-tolerated otherwise
Erythromycin Side Effects
- Gastrointestinal upset (nausea, vomiting, diarrhea)
- QT prolongation risk
- Multiple drug interactions via CYP3A4 inhibition
Critical Pitfalls to Avoid
Don't empirically cover MRSA in typical cellulitis: β-lactam monotherapy succeeds in 96% of cases even in high-MRSA-prevalence settings 1. Only add MRSA coverage (clindamycin, doxycycline, or TMP-SMX) when purulent drainage, penetrating trauma, or IV drug use is present.
Don't underdose clindamycin: Calculate actual weight-based dosing (≥10 mg/kg/day) rather than using standard 300 mg doses for all patients 3.
Don't use erythromycin as routine second-line: Resistance patterns make this obsolete. If β-lactam allergy exists, clindamycin is superior.
Don't add clindamycin to β-lactams routinely: Adding clindamycin to flucloxacillin provides no benefit (87% vs 81% improvement, p=0.174) but doubles diarrhea risk 5.
The Bottom Line Algorithm
For uncomplicated cellulitis:
- No penicillin allergy → Use cephalexin, penicillin, or amoxicillin
- Penicillin allergy → Use clindamycin (≥10 mg/kg/day)
- Purulent features or MRSA risk → Use clindamycin alone OR β-lactam + TMP-SMX/doxycycline
- Erythromycin → Avoid due to resistance; only consider if clindamycin unavailable and local susceptibility data supports use